|
Breakout Room Presentations
Room 0: How to Choose Key Reagents for CAR-T Cell Therapy Development
Teng Peng, PhD, Technique Application Manager, ACROBiosystems
Room 1: Effective Use of Science in the FDA Regulatory Process
Bethany Hills, Partner, Morrison & Foerster LLP
Keunbong (KB) Do, JD, PhD, Associate, Morrison & Foerster LLP
Room 2. Precise and Efficient Non-viral CRISPR Gene Editing Solutions
Lumeng Ye, PhD, Sr. Scientist, GenScript USA Inc.
Room 3: Humanized Models for Improved Preclinical Discovery and Assessment of Novel Immunotherapies
Jenna Frame, PhD, Manager, Scientific Communications & Marketing, Biocytogen Boston Corp.
Room 4: Atomic-resolution cryoEM and Its Impact on SBDD
Larry Jin, PhD, COO, Wuxi Biortus Biosciences Co., Ltd.
What’s Ahead for the Biotech Industry: Another Wave or Low Tide?
Michael Zhao, Co-founder, Q Bay (Boston)
Room 5: Clinical Study in the US and China
Charles Li, MBA, MS, VP, Business Development, CR Medicon, a Pharmaron Company
Next-Generation DMSO-Free & Serum-Free Cryopreservation for Cell Therapy Manufacturing and Processing
Xiaoxi Wei, PhD, Co-founder & CEO, X-Therma Inc.
User Affiliate at Lawrence Berkeley National Laboratory
Room 6: Future of Targeted Therapies in Lung Cancer
Sanjeev Redkar, MBA, PhD, President and Co-Founder, Apollomics Inc.
Room 7. Opportunities and Challenges in the Development of an Innovative Clinical Research Platform
Sophia Kan, Director of Marketing Strategy, GoBroad Healthcare Group
Alex J. Zhang, PhD, Chief Scientific Advisor, Hanhai International Inc.
|